IER3 and triple-A syndrome: Screening the differences between AAA and nonaneurysmal cells has identified two proteins, Solute Carrier Family 2 Member 3 (SLC2A3) and Immediate Early Response 3 (IER3), as a potential key targets strictly related to inflammation and immune response [165].